Dossier
clinicaltrials
trial early
Reducing Frailty for Older Cancer Survivors Using Supplements II
Key claim: A two-arm placebo-controlled RCT is testing whether a 12-week EGCG supplement reduces physical frailty versus placebo in pre-frail older cancer survivors.
Abstract
This study is a two-arm placebo controlled randomized clinical trial, to assess the effect of a 12-week EGCG intervention on physical frailty compared to placebo in pre-frail older cancer survivors.
Why this matters
A two-arm placebo-controlled RCT is testing whether a 12-week EGCG supplement reduces physical frailty versus placebo in pre-frail older cancer survivors.